Current and potential PI3K and BTK inhibitors for CLL
Update on venetoclax combination trials for elderly AML from ASH 2017
Preliminary results of the AIM trial of ibrutinib and venetoclax in mantle cell lymphoma
From Structure to Function to Clinical Outcome
CAR-T cell therapy debate: the future of lymphoma treatment?